Drugs Online |
 |
 | ||
|
Mofilet Cellcept |
|
| ||
Drugs Online » Prescription Drugs 11 » Mofilet Cellcept Mycophenolate is used for: Preventing organ rejection following kidney liver or heart transplants. This medicine is used in combination with other medicines. Mycophenolate (mye-koe-FEN-oh-late) belongs to a group of medicines known as immunosuppressive agents. It is used to lower the body's natural immunity in patients who receive organ transplants. Mycophenolate is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal cardiac or hepatic transplants. Mycophenolate should be used concomitantly with cyclosporine and corticosteroids. Buy Mofilet Cellcept and other Prescription Drugs 11 products online at Medstore. Buy Online at Medstore - Click Here!
About Mofilet Cellcept: Product Type: Prescription Drugs 11 Mofilet ( Cellcept Generic Mycophenolate ) Mofilet (Cellcept Generic Mycophenolate) Cellcept Generic Mycophenolate 250mg Cellcept Generic Mycophenolate Mofilet
View more Prescription Drugs 11 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
